We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
(+12%)
Cap. Flow
+$6.04B
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$740M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$544M |
| 3 |
NVIDIA
NVDA
|
+$407M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$276M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$232M |
| 2 |
Vanguard Large-Cap ETF
VV
|
+$58.3M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$46.4M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$40M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.26% |
| 2 | Financials | 3.77% |
| 3 | Consumer Discretionary | 2.12% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Genasys
GNSS
$75.6M
| $53.4K | ﹤0.01% |
21,794
| – | – |
|
3752
Kopin
KOPN
$663M
| $53K | ﹤0.01% |
21,811
+11,224
| +106% | +$22.9K |
|
3753
PUT
Apple
AAPL
$4.89T
| $52.2K | ﹤0.01% |
110,800
+600
| +0.5% | +$136K |
|
3754
CALL
Anavex Life Sciences
AVXL
$222M
| $51.5K | ﹤0.01% |
17,500
| – | – |
|
3755
Senseonics Holdings Inc
SENS
$254M
| $51K | ﹤0.01% |
5,849
-82
| -1% | -$792 |
|
3756
Banco Bradesco
BBD
$38.1B
| $50.4K | ﹤0.01% |
14,907
+669
| +5% | +$2.02K |
|
3757
Gossamer Bio
GOSS
$66.5M
| $49.1K | ﹤0.01% |
+18,655
| New | +$41.1K |
|
3758
PUT
UnitedHealth
UNH
$382B
| $48.8K | ﹤0.01% |
4,200
| – | – |
|
3759
InspireMD
NSPR
$32M
| $47.2K | ﹤0.01% |
19,569
+14
| +0.1% | +$34 |
|
3760
Annexon
ANNX
$855M
| $47.1K | ﹤0.01% |
+15,451
| New | +$38.4K |
|
3761
Milestone Pharmaceuticals
MIST
$144M
| $46.8K | ﹤0.01% |
23,410
| – | – |
|
3762
Holley
HLLY
$314M
| $46.7K | ﹤0.01% |
+14,877
| New | +$44.3K |
|
3763
GoodRx Holdings
GDRX
$1B
| $46.5K | ﹤0.01% |
11,003
-7,702
| -41% | -$33.9K |
|
3764
Alector
ALEC
$164M
| $46.5K | ﹤0.01% |
+15,721
| New | +$34.6K |
|
3765
Sabre
SABR
$656M
| $46.4K | ﹤0.01% |
25,365
+7,322
| +41% | +$17.3K |
|
3766
loanDepot
LDI
$548M
| $46.4K | ﹤0.01% |
+15,098
| New | +$34.9K |
|
|
LPRO
3767
Open Lending Corp
LPRO
$373M
| $45.4K | ﹤0.01% |
+21,509
| New | +$48.6K |
|
3768
CALL
Archer Aviation
ACHR
$3.64B
| $45.2K | ﹤0.01% |
10,000
| – | – |
|
3769
PUT
DoorDash
DASH
$75.3B
| $45.1K | ﹤0.01% |
+13,000
| New | +$3.26M |
|
3770
Cardlytics
CDLX
$21M
| $45K | ﹤0.01% |
1,852
| – | – |
|
3771
PodcastOne
PODC
$115M
| $44.8K | ﹤0.01% |
26,687
+6,559
| +33% | +$11.8K |
|
3772
Caribou Biosciences
CRBU
$156M
| $44.1K | ﹤0.01% |
18,922
-1,249
| -6% | -$2.36K |
|
3773
Galectin Therapeutics
GALT
$229M
| $44K | ﹤0.01% |
+10,385
| New | +$39.1K |
|
3774
Orchestra BioMed
OBIO
$224M
| $42.4K | ﹤0.01% |
17,101
+2,101
| +14% | +$5.8K |
|
3775
Cognition Therapeutics
CGTX
$82.3M
| $40.5K | ﹤0.01% |
30,004
+8,000
| +36% | +$10.9K |
|
Similar funds
Creative Planning's Q3 2025 Portfolio in Review
As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.
- Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
- Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
- Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
- Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
- Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
- Creative Planning opened 364 new positions and closed 133 in Q3 2025.
- Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.
Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.